The U.S. Senate health panel said on Tuesday it would vote this month on whether to subpoena Novo Nordisk to answer questions about U.S. prices for weight loss drugs Ozempic and Wegovy, which are far higher than those in other countries.
<p>WASHINGTON — A Senate health panel said on Tuesday it would vote this month on whether to subpoena Novo Nordisk to answer questions about U.S.
</p><p>&quot;The HELP Committee has reached out time and time again to Novo Nordisk to request their voluntary attendance at a hearing to discuss why they are charging Americans up to&a
Traffic Weather Sports Classifieds Cars Jobs Homes Television Radio Salt Lake Utah Local
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive’ U.S. Drug PricesRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsThe rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
Read more »
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsThe rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
Read more »
Why Lilly And Novo Nordisk Will Keep Dominating The Market For Blockbuster GLP-1 DrugsAlex Knapp is a senior editor at Forbes covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study saysThe results shed light on the long-term effects of Wegovy, and could boost Novo Nordisk's case to insurers and governments to cover the costly drug.
Read more »
Ozempic vs Krispy Kreme: Wall Street firm bets weight-loss drugs won’t beat doughnut salesWall Street firm Truist Securities is betting that consumers will still buy Krispy Kreme doughnuts amid the surge in weight-loss drugs like Novo Nordisk's Ozempic.
Read more »